Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

David Rulnick

Physician Assistant Haddonfield, NJ Physician Assistant

NPI 1881379535 CMS profile 11510978

807 N Haddon Ave, Haddonfield, NJ 08033

Open in the dashboard

General payments

$1,519

93 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Rulnick of Haddonfield, NJ is reported in the CMS Open Payments database as having received $1,519 across 93 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $53 3
2024 General $1,102 69
2023 General $364 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Rulnick
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to David Rulnick were reported at $53. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year David Rulnick Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $364 $167 $52–$557 $160
2024 $1,102 $178 $55–$600 $164
2025 $53 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Collegium Pharmaceutical, Inc. $492 30 payments
  2. Scilex Pharmaceuticals Inc. $369 29 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $241 20 payments
  4. Vertos Medical, Inc. $203 3 payments
  5. SI-BONE, Inc. $37 1 payment
  6. International Rehabilitative Sciences, Inc $32 1 payment
  7. Protega Pharmaceutials LLC $30 2 payments
  8. IBSA Pharma Inc. $29 2 payments
  9. ConvaTec Inc. $19 1 payment
  10. Boston Scientific Corporation $18 1 payment
  11. Other $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $1,519 93 payments
Products named General payments · program years 2023–2025
  1. BELBUCA $492 30 payments
  2. ZTLido $369 29 payments
  3. RELISTOR $226 19 payments
  4. mild Device Kit $203 3 payments
  5. RS 4i Plus Sequential Stimulator $32 1 payment
  6. ROXYBOND $30 2 payments
  7. Tirosint $29 2 payments
  8. Licart $29 2 payments
  9. AQUACEL AG+ EXTRA $19 1 payment
  10. General - Pain Management $18 1 payment
  11. Other $80 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 38 drugs

Part D claims

6,092

Median for Physician Assistant: 241

Drug cost

$427,389

Median for Physician Assistant: $4,110

Branded share of claims

27.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Relistor Methylnaltrexone Bromide Brand 32 $73,217
Ztlido Lidocaine Brand 78 $57,105
Oxycontin Oxycodone Hcl Brand 121 $50,088
Belbuca Buprenorphine Hcl Brand 69 $49,797
Lidocaine Generic 264 $32,815
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 819 $22,475
Diclofenac Sodium Generic 317 $21,614
Oxycodone Hcl Generic 1,102 $21,585
Buprenorphine Generic 55 $15,207
Movantik Naloxegol Oxalate Brand 21 $10,023

The 10 drugs with the highest cost, of 38 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$34,450

Medicare's payments for the services billed

Medicare patients

237

Average age 67

Services billed

681

151 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 38%
Depression 32%
COPD 30%
Ischemic heart disease 27%
Chronic kidney disease 24%
Heart failure 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BELBUCA
  • Collegium Pharmaceutical, Inc. $326
$326 69 —
ZTLido
  • Scilex Pharmaceuticals Inc. $288
$288 78 —
RELISTOR
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $190
$190 32 —
ROXYBOND
  • PROTEGA PHARMACEUTIALS LLC $30
$30 — —
Tirosint
  • IBSA Pharma Inc. $12
$12 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record